




Title:  The feasibility of psychometric measures for body image and lymphedema 






Research Question: To assess the feasibility of the MGSIS-5and G3L-20 in a 
community sample of cisgender men aged 40 years and older 
Research problem: Psychometric measures can aid urologic practice by 
prompting patients to talk about aspects of their body that are either too sensitive or a 
natural part of aging.  Importantly, reliable and valid measures can also contribute to a 
an evidenced-based-practice-based-evidence cycle where they can establish the 
impact of changes recommended by research while using the results in turn to inform 
research.  In this study, we examine two psychometric measures on the opposite ends 
of a psychological-physical continuum; the Male Genital Self-Image Scale (MGSIS-
5) and the Groin and Lower Limb Lymphedema questionnaire (G3L-20)   
Methodology: Non-experimental psychometric design administering the 
questionnaires online to a community sample of cisgender men aged 40 years old and 
above.  Validity and reliability analyses were conducted. 
 Results: 30 men completed the study; 14 aged 40-49, 14 aged 50-59 and 2 
aged 60-69.  The MGSIS-5 and G3L-20 show acceptable reliability and validity with 
one- and three-component structures respectively.   
Conclusions: The MGSIS-5 and G3L-20 show sufficient feasibility to justify 
the resources for studies with larger community samples and for pilot studies with 
clinical populations. 





 The feasibility of psychometric measures for body image and lymphedema for 
routine practice 
Psychometric measures can aid urologic nursing.  There are reports of a 
reluctance of men to disclose treatment effects to others, due to embarrassment, fear 
of appearing weak, and/or the loss of masculine capital 1 or because the impact on 
their body of their condition is too traumatising 2.  Mroz et al. 3 found that although 
men did on occasion open up about their experiences; they often spoke in general 
terms rather than discussing detail, particularly about the emotional consequences of 
their physical symptoms. Men are likely to couch their discussions about sensitive 
topics in humour, perhaps in an attempt to safely reveal emotional states without 
revealing too much vulnerability 4–6. This can make communication challenging for 
health professionals, especially as sexual and urinary functioning can be considered 
intimate and off-limits for discussion with strangers 7. The prevalence of many 
urological conditions increases with age, and Balderson and Towell 8 suggest that 
older men in particular are likely to suffer in silence.   Also, changes in sexual and 
urinary function are often considered to be natural and expected with age 9 and 
therefore go unmentioned.  Consequently, psychometric measures may prove useful; 
particularly because some men are more likely to monitor their health by numbers 
than subjective feelings 10 and that a questionnaires gives tacit approval required to 
free patients up to discuss an issue 11, which is evidenced with more in-depth 
discussion on the questionnaire topic with a clinician 12. 
Furthermore, the routine use of psychometric measures in urological nursing 
offers a virtuous evidenced-based-practice-based-evidence circle 13.  The use of 
carefully selected psychometric measures can, for example, help establish the impact 
of changes in practice recommended by research.  In turn, the results from reliable 
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and valid measures from routine practice can inform research.  This is particularly 
important for rare conditions in urological nursing that struggle to gain the resources 
for developments in either practice or research.  Where psychometric measures are 
routinely collected, these could be – with patient consent – used to complement 
practice and research developments, minimizing costs.  The International Penile 
Advanced Trial (InPACT; ISRCTN13580965), is an example that aims to determine i) 
if there is a role for neoadjuvant therapy in this patient group and ii) if prophylactic 
pelvic lymph node dissection improves survival in patients at high risk of recurrence 
following inguinal lymph node dissection.  InPACT has included a psychometric 
measure to examine quality of life but this adds to the financial burden of a study that 
is already complicated by governance across international borders and time (requiring 
ten years to recruit sufficient participants).  This paper two considers two potential 
areas for urological practice that are at the opposite end of a continuum of 
psychological-physical; genital body image and lymphedema. 
Body Image 
A body image is a representation (the ‘image’) that an individual has about 
their material form.   Schilder 14 introduced the notion of body image in reference to 
physiology and phenomenology.  There are, for example, “tactile, thermal, pain 
impressions” from the “muscles” as well as “the immediate experience that there is a 
unity of the body” 14(p11).  In relation to body image, some parts of the body are 
particularly important sources of information as 1) a site of breach between the body 
and outer world and 2) a location of inner, bodily sensation.  As Schilder explains, the 
mouth, urethra and anus are openings into and out of the body and through which “we 
come in closest contact with the world” 14(p124).  Like irritated skin compelling an 
itch, the genitals, for example, forces “the individual into a continual contact with the 
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outside world, and there is no question that we discover our bod at least partially by 
these contacts with the outside world” 14(p125).  A genital body image measure could 
examine satisfaction with the i) appearance, size and feelings towards the genitals in 
general as well as the ii) appearance, amount, colour, shape, size, smell, and texture of 
the parts. 
Measuring genital body image could be useful across a range of urological 
practice.  Asking patients to complete a questionnaire before an appointment could, 
for example, give them tacit approval 11 to talk about issues that they find sensitive 
because it is challenging to their sense masculinity 2,5,15–18, easing communication 
between patient and health professionals.  The European Organisation for Research 
and Treatment of Cancer Quality of Life measure EORTC-QLQ; 19, Clinical Outcomes in 
Routine Evaluation CORE; 20 and the International Index of Erectile Function IIEF; 21 are 
examples of psychometric measures used that are both well validated and general 
enough that they can be used across a range of settings.  The EORTC-QLQ and the 
CORE-6D are specific to caner care and psychological services respectively, although 
one could argue that the questions are general enough that they could be used in any 
clinical setting.  Nevertheless, the questions may be so generic that they are not useful 
for urologic practice.  It is unlikely, for example, that the questions would prompt 
patients to talk about their genitals.  In contrast, the IIEF is relevant for urological 
practice, but its focus on erectile function means it is arguably insensitive for those 
patients who have lost function, such as due to penectomy.  Instead, genital body 
image could offer the right balance in being relevant for urological conditions while 
still being general enough that it avoided a proliferation of measures.  There Male 
Genital Self-Image Scale is a short measure that could be useful although it has to 




Lymphedema is a useful counterpoint to genital body image because it is 
focused on a specific set of physical symptoms rather than a psychological 
construction.  Indeed, there are a wide range of questionnaires examining physical 
symptoms, such as pain; these are treated as if they are diagnostic tools although there 
are technically psychometric measures attempting to quantify a person’s subjective 
experience of their body.  A consequently, a psychometric measure of genital and 
lower limb lymphedema offers much of the same potential benefits of a genital body 
image measure; it may prompt patients to talk about pain and swelling in their groin 
and lower limbs and, if a clinical threshold is met, could direct health professionals to, 
for example, follow up with a physical examination.   
The Gynaecologic Cancer Lymphedema Questionnaire was developed as a 
diagnostic tool for women who had received a diagnosis of and treatment for specific 
gynaecological cancers to identify lymphedema in the lower extremities GCLQ-20; 23.  
Only a single item is sex-specific, so this could easily be adapted for men as the Groin 
and Lower Limb Lymphedema scale (G3L-20).  Noble-Jones 24 recent research on the 
Lymphoedema Genitourinary Cancer Questionnaire does something similar with male 
patients but was published after the research in this manuscript commenced thus 
demonstrating the importance of this topic at this time. 
Aims 
To be able to examine the reliability and validity of genital body image and 
lymphedema psychometric measures with urology patients, it is important to examine 
their use in community populations first.  Furthermore, psychometric tests must 
reflect the demographics of those most commonly identify with the conditions they 
measure.  Consequently, the aim of this study is to assess the feasibility of the 
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MGSIS-5and G3L-20 in a community sample of cisgender men aged 40 years and 
older.  
Method 
This study used a non-experimental psychometric design to administer the 
questionnaires and assess their psychometric properties. 
Participants 
The aim of the sampling strategy was to recruit cis-gender male participants 
who reflected the age of the population of interest and who self-identified as healthy 
and residing in the United Kingdom.  From those completing the questionnaires, 30 
were suitable for inclusion.  To ensure data collection was in proportion to the aims of 
a feasibility study, the only demographic information collect was self-reported age 
category at the time of completion; 14 were aged 40-49, 14 were 50-59, and 2 were 
60-69.    
 
Materials 
The study used two questionnaires. The first was the five-item male genital 
self-image scale MGSIS-5; 22.  The items were; I feel positive about my genitals, I am 
satisfied with my genitals, I would feel comfortable letting a sexual partner look at my 
genitals, I think my genitals work the way they are supposed to work; and I am not 
embarrassed about my genitals.  Responses on the MGSIS-5 were given using a 4-
option Likert with ‘agreement’ showing positive genital self-image; Strongly agree = 
4, agree = 3, disagree = 2, strongly disagree =1.   
The second questionnaire was an adapted version of the Gynecologic Cancer 
Lymphedema Questionnaire GCLQ; 23.  The GCLQ was originally developed for 
gynecologic cancer survivors and had 20 items that were answered yes/no.  The 
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questionnaire asked if the respondent had experienced limited movement, weakness, 
tenderness, swelling, redness, blistering, firmness, increased temperature, heaviness, 
numbness, stiffness, aching or pockets of fluid in the groin and lower limbs in the last 
four weeks.  All but one questions were suitable regardless of sex identity, except for 
number 19 which clarified that ‘grown swelling’ related to the ‘labia/vulvar’.  In the 
adapted version used in this study – termed the Groin and Lower Limb Lymphedema 
scale (G3L-20) – labia/vulvar was removed (See Table 1).   The yes/no answers are 
scored as 1 and 0 respectively, which means a higher score (from 0 to 20) shows 
greater experience in the range of symptoms associated with lower limb lymphedema.  
Carter et al. (ibid.) showed the plausible clinical cut-off scores are in the range of 3 to 
6. 
INSERT TABLE 1 AROUND HERE 
Statistical Analysis 
Validity was examined using an exploratory factor analysis to identify 
psychometric factors, which was followed by a confirmatory factor analysis.  Internal 
reliability of the items in each measure was assessed using Chronbach’s alpha.  To 
minimize risk of bias in the statistical analysis, the proposal was registered before 
data collection and the data was archived to allow others to check and reuse 25. 
Procedure 
The study was administered online.  Invitations to participate were shared on 
social media and websites who had men aged 40 years and older as their audience, 
such as the NHS Men’s Health forum (https://healthunlocked.com/menshealth).  
Actively clicking a link in the invitation took participants to a page explaining the 
study.  Again, participants had to actively click a link to find the questionnaire. The 
study started by confirming UK residence, age and that they were free from illness.  
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Those that met the inclusion criteria were taken on to complete the MGSI and the 
G3L-20; 15 respondents attempted the study but because they did not meet the 
inclusion criteria were branched to the end.  Only at the end when respondents 
confirmed their responses was data stored.  The questionnaire was hosted on 
Microsoft Forms, which met standard C of the Office 365 Compliance Framework for 
security and privacy 26.   
Research Governance 
Ethical review was provided under the University of Bradford Research with 
Human Participants policy.  Limited demographic – for example, age range rather 
than age – information was collected to minimize intrusion.  Consent was explicit at 
the start of the questionnaire (those not consenting where branched to the end of the 
online form) and included public archiving of the study data to confirm the analysis in 
this paper and to facilitate secondary analyses. 
Findings 
Male Genital Self-Image Scale (MGSIS-5) 
The first questionnaire is the Male Genital Self-Image Scale.  The means for 
the individual questions and total score of the MGSIS-5 indicate a positive genital 
self-image in the tested participants with 70% either agreeing or strongly agreeing 
with all positive items (See Table 2). Only two (6.7%) participants reported that they 
did not feel positively about their genitals, and only one (3.3%) reported that he 
would not feel comfortable letting a sexual partner look at their genitals. In total, four 
participants (13.3%) each suggested a dissatisfaction with appearance, a belief that 
their genitals did not work as they were supposed to, and embarrassment towards their 
genitals. There were very few differences in scores between age groups. The most 
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notable difference is in the question about genital function which elicited a slightly 
lower score in those aged 50-59 compared with the 40-49 year-old group.  
INSERT TABLE 2 AROUND HERE 
A principal component analysis (PCA) was performed to assess the 
psychometric components of the MGSIS-5. The correlation matrix indicated that all 
variables had at least one correlation coefficient over 0.3. Further, the Kaiser-Meyer-
Olkin measure (KMO) had a value of 0.80, suggested by Kaiser 27 to be ‘meritorious’ 
and indicating an adequate sample.  Finally, Bartlett’s test of Sphericity was 
statistically significant (p < .0005).  All of these results suggested that PCA was an 
appropriate analysis to perform on the data.  
Only one component with an eigenvalue above one emerged from the PCA 
and explained 68.45% of the variance (See Table 3). A second component with an 
eigenvalue of 0.79 would explain a further 15.70% of the variance, however, from 
scrutinizing the scree plot and the component matrix it was decided that this was not 
significant. From the available data, the MGSIS-5 appears to be measuring only one 
meaningful component.  
INSERT TABLE 3 AROUND HERE 
Cronbach’s Alpha was used to ascertain the internal consistency reliability. 
The data produced a score of 0.88 indicating a high level of internal consistency. 
Similarly, no item deletion would result in a higher Cronbach’s Alpha, suggesting that 
each individual question is appropriate to the scale.   
Groin and Lower Limb Lymphedema Scale (G3L-20) 
The mean total score for the G3L-20 was 1.20 with a standard deviation of 
3.54 (see Table 4). As Carter 23 showed that plausible clinical cut-off scores are in the 
range of 3 to 6, there is some risk of erroneously detecting lymphedema.  In this 
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study, a clinical cut-off of 6 would mean that all participants would have been 
correctly identified as free from lymphedema.  
Insert Table 4 Around Here 
There were only 2 participants aged 60-69 and they responded negatively to 
every question on the GCLQ, so their individual scores have not been reported here. 
There were some differences in scores between the 40-49 and the 50-59 age group. 
Those aged 50-59 had a slightly higher overall score, and a far higher response in the 
affirmative to the question about aching. Nearly two thirds (64.3%) of 50-59-year-old 
participants said that they had experienced aching in their lower body, as compared to 
14.3% in the 40-49 age group.  There were no participants who answered in the 
affirmative to questions regarding hip swelling and groin swelling, so these were 
removed from further analysis as there was no variation to measure. 
It was not possible to produce the KMO measure of Bartlett’s test of 
Sphericity. Although all variables did have a correlation coefficient about 0.3, the 
other assumptions necessary to perform PCA could not be tested, which means the 
results should be approached with caution.  
A total of five components with an eigenvalue greater than one emerged in the 
analysis, which explained 85.72% of the variance in total (45.91%, 17.33%, 9.91%, 
6.69% and 5.89% respectively; see Table 5).  However, the scree plot suggested that 
only three of these components should be retained, hence it was decided that a three-
component model which explained 73.15% of the variance was the best fit and had 
the benefit of a simpler structure. There was some overlap between components, but 
component one strongly loaded to items regarding the feeling and function of the 
underlying structure of the legs, while component two loaded to items regarding the 
exterior feeling and function of the skin. Component three mainly loaded to items 
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related to the skin’s appearance, although it did also load to the question regarding 
limited movement of the hip.  
Insert Table 5 Around Here 
As with the MGSIS-5 data, Cronbach’s Alpha was used to ascertain the 
internal consistency reliability coefficient. The score of 0.92 suggests that the adapted 
GCLQ has a very high level of internal consistency. The data does suggest that the 
removal of questions regarding limited movement of the hip, limited movement of the 
toes, or increased temperature of the leg would result in a higher score, however the 
increase would not be great enough to definitively recommend the removal of these 
items. 
Conclusions 
The aim of this paper was to examine the feasibility of the MGSI-5 and the 
G3L-20 for use in UK clinical urology groups aged.  This was achieved through a 
psychometric study of the two measures in a community sample of men aged 40 years 
and above.  The data analysis shows that we can conclude that the resources would be 
justified for larger community samples and it would be appropriate to assess their 
feasibility in clinical populations. 
MGSI 
The MGSI was first developed in young male community sample, so this 
study shows good feasibility in for men in the UK.  At present, there is no information 
from which plausible clinical cutoffs could be developed, so studies comparing 
community and clinical groups would be useful.  Even without clinical cutoffs, 
completing the MGSI before meeting a health professional may prime patients to 
discuss their genitals.  This means that future studies into the utility of the MGSI in 
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urology groups should not limit themselves to psychometric designs so that they are 
open to examining how their use impacts on clinical encounters. 
The results tend to lend support to the validity of both the MGSIS-5 and the 
adapted version of the GCLQ in UK based men aged 40 and over. The means for the 
individual item scores were very similar to those obtained in the original paper on the 
development and validation of the MGSIS-5 by Herbenick et al. 22, who also arrived 
at a one component solution.  
The question with the highest mean score (3.43) was related to comfort with 
letting a sexual partner look at the participants’ genitals, while the lowest mean (3.10) 
was about satisfaction with appearance. Initially, this may appear counterintuitive as it 
would make sense for comfort felt when someone else can see a man’s genitals to be 
related to his perception of their appearance. However, it may be that the men 
questioned associated a partner looking at their genitals with some pleasurable sexual 
activity and thus would be less concerned with issues surrounding genital appearance. 
It is not known whether there would be a difference in ratings were the question 
simply asking about the prospect of anyone else looking at the participants’ genitals 
rather than specifically a sexual partner, though it seems reasonable to assume that in 
that instance the score would be more closely related to the man’s perception of his 
genital appearance. Nevertheless, the focus on the sexual aspect may have more 
utility, as it could suggest whether poor genital self-image is interfering with a man’s 
engagement with and enjoyment of healthy sexual activity. 
GCLQ 
The mean total score of the participants measured here (1.97) matched closely 
with that of the group without a diagnosis of lymphedema (1.63) in the original study 
in women (Carter et al. 2010)23. This suggests that the adapted version of the GCLQ 
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was not detecting lymphedema in participants in error and that it would be an 
appropriate measure to use in men of this demographic. Similarly, the internal 
reliability coefficient (Cronbach’s Alpha) was high (0.92) and tallied well with the 
original research (0.95), confirming a good level of internal reliability for the 
measure. The analysis did show indicate a three-factor structure but the crossovers 
between some questions this should be taken cautiously.  Nevertheless, these findings 
justify the resources for a replication with a larger community sample, which would 
most likely result in a more discrete component structure.  
It is difficult to directly compare the results obtained here with those from the 
original development paper by Carter et al. 23 as they were measuring very different 
demographics. While the original was comparing women both with and without a 
diagnosis of lymphedema who had experienced cancer treatment, the present study 
was measuring healthy men. Perhaps due to this, some of the responses for individual 
items differed quite significantly, but the similarity in the means of the total scores 
demonstrate a promising synchronicity that suggests the validity of the measure in a 
male cohort.  
The most striking age difference appears in the question related to aching. 
Only 14.3% of participants in the 40-49 age group answered in the affirmative to this 
question, as compared with 64.3% of those aged 50-59. Molton and Terrill 28 suggest 
that incidences of chronic pain begin to increase after 45, which may be an 
explanation for this result.  However, the difference in reported lower body aches 
found here appears to be particularly large. Though there were only two participants 
aged 60-69, neither of those reported aching. Should the increase in aching be so 
significant after 45, it would be expected that it would continue beyond that point, 
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which from these results does not appear to be the case. It would be interesting to see 
if this effect is still evident in a larger community sample.  
The questions with the next highest affirmative response were related to 
numbness and limited movement of the knee, both of which were reported by 16.7% 
of the participants. Relph and Herrington 29 report that a reduction in knee mobility is 
common as a person ages, which could explain why this was one of the most 
commonly reported issues. Issues surrounding numbness is more difficult to explain, 
as numbness is generally not a common sign of ageing but usually a symptom of 
some neuropathic illness or injury 30. As participants were asked to confirm that they 
did not have a specific illness which could affect the function of their lower limbs, the 
question may be poorly worded and causing confusion. It is possible that some 
participants classified a common phenomenon such as pins and needles as numbness. 
This may be something which requires further clarification in the future use of the 
G3L-20.  
Limitations 
Feasibility studies are an important step in the development of psychometric 
measures.  Nevertheless, the nature of statistics employed in this study means that 
robustness of the findings increases along with the sample size 31, which means are 
futures studies with larger samples are important.  Temporal reliability was not 
explored here but is nevertheless important, particularly for a measure that could have 
clinical applications.  Future studies should include examining test-re-tests reliability. 
The online based recruitment method may have affected the representativeness 
of the sample 32, particularly among the target demographic. Weigold et al. 33 suggest 
that results obtained from older adults results could be quantitatively and qualitatively 
different than if they had completed the measures using same pen and paper. They 
16 
 
posit that relative unfamiliarity with the technology could contribute to increased 
strain on the participants’ processing capacity, resulting in inaccurate results.  This 
could explain the imbalance in participation as age increased. 28 of the 30 participants 
whose data could be used were aged between 40 and 59, while only two were 60-69. 
There was only one person aged 70 or over who participated, but unfortunately his 
data could not be used as he had a pre-existing condition. However, as the present 
study was self-selecting, it seems likely that participants already had a certain level of 
familiarity with the technology 
In older adults, self-selecting samples on Internet-based studies can have 
unique characteristics 34–37, such as have increased psychological wellbeing 38.  As a 
community population study, this is a potentially beneficial bias although it does 
reinforce the importance of developing these measures with clinical populations.  
However, when developing clinical cut-offs, it is important to avoid over-inflating or 
deflating baseline scores.  Future community and clinical studies will have to avoid an 
overreliance on Internet-based recruitment. 
 
Box 1: What this manuscript contributes 
• The Male Genital Self-Image Scale (MGSIS-5) has been developed in a young 
American population and could be useful in routine urological practice, such 
as for prompting patients to talk about sensitive issues during an initial 
assessment  
• The Gynecologic Cancer Lymphedema Questionnaire could be adapted for use 
with men, directing health professions to consider lymphedema when clinical 
cut-offs are reached 
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• Both the MGSIS-5 and the Groin and Lower Limb Lymphedema scale (G3L-
20) show good feasibility, which justifies the resources for larger community 
samples and feasibility trails in clinical populations 
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Table 1: G3L-20* 
 
All questions have yes/no options 
The following questions regard your experiences with movement, use and 
sleep in the past 4 weeks. 
1. Do you have limited movement of your hip? 
2. Do you have limited movement of your knee? 
3. Do you have limited movement of your ankle? 
4. Do you have limited movement of your foot? 
5. Do you have limited movement of your toes? 
6. Does your leg or foot feel weak? 
The following questions relate to symptoms you might experience in your 
foot, leg, hip, groin or your lower body in the past 4 weeks. 
7. Have you experienced tenderness? 
8. Have you experienced swelling? 
9. Have you experiences swelling with pitting? (Pitting is when you press firmly 
on your skin and the dent stays long enough to feel it when you slide the pad 
of your finger across it.) 
10. Have you experienced redness? 
11. Have you experienced blistering? 
12. Have you experienced firmness/tightness? 
13. Have you experienced increased temperature in your leg? 
14. Have you experienced heaviness? 
15. Have you experienced numbness? 
16. Have you experienced stiffness? 
17. Have you experienced aching? 
18. Have you experienced hip swelling?  
19. Have you experienced groin swelling? 
20. Have you experienced pockets of fluid? 
* Adapted from the Gynaecologic Cancer Lymphedema Questionnaire (GCLQ; 




Table 2: Descriptive statistics for MGSIS-5 by age group 
 












14 3.36 0.84 2 3.50 0.71 14 3.29 0.61 30 3.33 0.71 







14 3.07 0.83 2 3.50 0.71 14 3.07 0.62 30 3.10 0.71 
I think my 
genitals 
work the 
way they are 
supposed to 
work 
14 3.43 0.85 2 3.50 0.71 14 3.43 0.51 30 3.43 0.68 
I am not 
embarrassed 









14 3.14 1.10 2 4.00 0.00 14 3.21 0.70 30 3.23 0.90 






Table 3: Component matrix for the MGSIS-5 
 
  
 Component  Communalities 
I feel positively about my 
genitals 
0.85 0.72 
I am satisfied with the 
appearance of my genitals 
0.93 0.86 
I would feel comfortable letting 
a sexual partner look at my genitals 
0.82 0.68 
I think my genitals work the 
way they are supposed to work 
0.74 0.54 






Table 4: Descriptive statistics for the G3L-20* 
 
Age 40-49 50-59 All 
 N Yes 
(%) 
No (%) N Yes 
(%) 
No (%) N Yes (%) No (%) 
Do you have limited movement of your hip? 14 2(14.3) 12(85.7) 14 1(7.1) 13(92.9) 30 3(10) 27 (90) 
Do you have limited movement of your knee? 14 2(14.3) 12(85.7) 14 3(21.4) 11(78.6) 30 5 (16.7) 25 (83.3) 
Do you have limited movement of your ankle? 14 1(7.1) 13(92.9) 14 1(7.1) 13(92.9) 30 2 (6.7) 28 (93.3) 
Do you have limited movement of your foot? 14 1(7.1) 13(92.9) 14 1(7.1) 13(92.9) 30 2 (6.7) 28 (93.3) 
Do you have limited movement of your toes? 14 0 (0) 14(100) 14 2(14.3) 12(85.7) 30 2 (6.7) 28 (93.3) 
Does your leg or foot feel weak? 14 1(7.1) 13(92.9) 14 2(14.3) 12(85.7) 30 3 (10) 27 (90) 
Have you experienced tenderness? 14 1(7.1) 13(92.9) 14 3(21.4) 11(78.6) 30 4 (13.3) 26 (86.7) 
Have you experienced swelling? 14 1(7.1) 13(92.9) 14 1(7.1) 13(92.9) 30 2 (6.7) 28 (93.3) 
Have you experienced swelling with pitting? 14 1(7.1) 13(92.9) 14 0 (0) 14(100) 30 1 (3.3) 29 (96.7) 
Have you experienced redness? 14 1(7.1) 13(92.9) 14 1(7.1) 13(92.9) 30 2 (6.7) 28 (93.3) 
Have you experienced blistering? 14 0 (0) 14(100) 14 1(7.1) 13(92.9) 30 1 (3.3) 29 (96.7) 
Have you experienced firmness/tightness? 14 1(7.1) 13(92.9) 14 1(7.1) 13(92.9) 30 2 (6.7) 28 (93.3) 
Have you experienced increased temperature in your 
leg? 
14 1(7.1) 13(92.9) 14 2(14.3) 12(85.7) 30 3 (10) 27 (90) 
Have you experienced heaviness? 14 1(7.1) 13(92.9) 14 2(14.3) 12(85.7) 30 3 (10) 27 (90) 
Have you experienced numbness? 14 1(7.1) 13(92.9) 14 4(28.6) 10(71.4) 30 5 (16.7) 25 (83.3) 
Have you experienced stiffness? 14 2(14.3) 12(85.7) 14 4(28.6) 10(71.4) 30 6 (20) 24 (80) 
Have you experienced aching? 14 2(14.3) 12(85.7) 14 9(64.3) 5(35.7) 30 11 (36.7) 19 (63.3) 
Have you experienced hip swelling? 14 0 (0) 14(100) 14 0 (0) 14(100) 30 0 (0) 30 (100) 
Have you experienced groin swelling? 14 0 (0) 14(100) 14 0 (0) 14(100) 30 0 (0) 30 (30) 
Have you experienced pockets of fluid? 14 1(7.1) 13(92.9) 14 1(7.1) 13(92.9) 30 2 (6.7) 28 (93.3) 
          
 N Mean SD N Mean SD N Mean SD 
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Total Score 14 1.43 3.99 14 2.79 3.21 30 1.97 3.54 




Table 5: Rotated component matrix with Varimax rotation for the G3L-20 
  
 1 2 3 Comm 
Do you have limited movement of your hip? 0.10 0.05 0.59 0.37 
Do you have limited movement of your knee? 0.64 0.57 0.15 0.77 
Do you have limited movement of your ankle? 0.81 -
0.01 
0.51 0.91 
Do you have limited movement of your foot? 0.81 -
0.01 
0.51 0.91 
Do you have limited movement of your toes? 0.71 -
0.12 
-0.20 0.56 
Does your leg or foot feel weak? 0.82 0.03 0.32 0.77 
Have you experienced tenderness? 0.04 0.55 0.50 0.55 
Have you experienced swelling? 0.15 0.69 0.68 0.97 
Have you experienced swelling with pitting? 0.30 0.04 0.93 0.95 
Have you experienced redness? 0.15 0.69 0.68 0.97 
Have you experienced blistering? -
0.09 
0.92 0.02 0.85 
Have you experienced firmness/tightness? 0.15 0.69 0.68 0.97 




0.77 -0.16 0.62 
Have you experienced heaviness? 0.76 -
0.01 
0.38 0.71 
Have you experienced numbness? 0.56 0.51 0.28 0.65 
Have you experienced stiffness? 0.58 0.44 0.18 0.57 
Have you experienced aching? 0.58 0.50 0.01 0.58 
Have you experienced pockets of fluid? 0.33 -
0.05 
-0.63 0.51 
 
 
 
